A detailed history of Oppenheimer & CO Inc transactions in Alcon Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 14,996 shares of ALC stock, worth $1.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,996
Previous 13,304 12.72%
Holding current value
$1.25 Million
Previous $1.19 Million 26.58%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$88.07 - $100.79 $149,014 - $170,536
1,692 Added 12.72%
14,996 $1.5 Million
Q2 2024

Aug 07, 2024

SELL
$77.58 - $92.26 $16,524 - $19,651
-213 Reduced 1.58%
13,304 $1.19 Million
Q1 2024

May 06, 2024

BUY
$74.84 - $88.15 $19,009 - $22,390
254 Added 1.92%
13,517 $1.13 Million
Q4 2023

Feb 13, 2024

BUY
$69.57 - $78.12 $8,626 - $9,686
124 Added 0.94%
13,263 $1.04 Million
Q3 2023

Nov 07, 2023

SELL
$76.74 - $85.2 $40,288 - $44,730
-525 Reduced 3.84%
13,139 $1.01 Million
Q2 2023

Aug 02, 2023

SELL
$69.16 - $82.11 $14,454 - $17,160
-209 Reduced 1.51%
13,664 $1.12 Million
Q1 2023

May 10, 2023

SELL
$64.46 - $77.23 $756,760 - $906,680
-11,740 Reduced 45.84%
13,873 $978,000
Q4 2022

Feb 07, 2023

SELL
$56.51 - $71.71 $309,674 - $392,970
-5,480 Reduced 17.62%
25,613 $1.76 Million
Q3 2022

Nov 14, 2022

SELL
$56.96 - $78.09 $8,771 - $12,025
-154 Reduced 0.49%
31,093 $1.81 Million
Q2 2022

Aug 08, 2022

SELL
$64.25 - $81.25 $9,123 - $11,537
-142 Reduced 0.45%
31,247 $2.18 Million
Q1 2022

May 12, 2022

SELL
$71.65 - $87.13 $46,859 - $56,983
-654 Reduced 2.04%
31,389 $2.49 Million
Q4 2021

Feb 02, 2022

SELL
$77.91 - $88.5 $94,504 - $107,350
-1,213 Reduced 3.65%
32,043 $2.79 Million
Q3 2021

Nov 12, 2021

BUY
$68.18 - $87.25 $34,090 - $43,625
500 Added 1.53%
33,256 $2.68 Million
Q2 2021

Aug 03, 2021

BUY
$66.27 - $76.21 $780,594 - $897,677
11,779 Added 56.15%
32,756 $2.3 Million
Q1 2021

May 10, 2021

SELL
$65.32 - $76.01 $168,133 - $195,649
-2,574 Reduced 10.93%
20,977 $1.47 Million
Q4 2020

Feb 11, 2021

SELL
$56.82 - $66.57 $101,821 - $119,293
-1,792 Reduced 7.07%
23,551 $1.55 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $62.39 $244,779 - $276,512
-4,432 Reduced 14.88%
25,343 $1.44 Million
Q2 2020

Aug 11, 2020

SELL
$49.45 - $64.16 $205,514 - $266,648
-4,156 Reduced 12.25%
29,775 $1.71 Million
Q1 2020

May 08, 2020

SELL
$39.86 - $63.46 $260,923 - $415,409
-6,546 Reduced 16.17%
33,931 $1.72 Million
Q4 2019

Feb 07, 2020

SELL
$55.04 - $59.27 $218,288 - $235,064
-3,966 Reduced 8.92%
40,477 $2.29 Million
Q3 2019

Oct 31, 2019

SELL
$58.2 - $62.42 $76,882 - $82,456
-1,321 Reduced 2.89%
44,443 $2.59 Million
Q2 2019

Aug 09, 2019

BUY
$54.43 - $63.33 $2.49 Million - $2.9 Million
45,764 New
45,764 $2.84 Million

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $40.9B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.